- Natera's FDA Breakthrough Device designation for its multi-cancer blood test pushes shares near all-time highs. - The ...
Natera’s Multi-Cancer Early Detection Assay Receives FDA Breakthrough Designation, Targeting Screening Gaps / Breakthrough ...
China had built 5.195 million 5G base stations by the end of August, accounting for 39.7 percent of all mobile base stations. 3. October 3 marks the 13th anniversary of the proposal to jointly build ...
The Federal Investigation Agency has made a major breakthrough in the death of 22-year-old IIUI Gold Medalist Laiba Ijaz, ...
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
HIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing ...
Natera said on Oct. 9 that the FDA granted Breakthrough Device designation after reviewing data across 12 cancer types; ...
InvestorsHub on MSN
Natera receives FDA breakthrough device designation for multi-cancer early detection blood test
Natera (NASDAQ:NTRA) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its investigational multi-cancer early detection (MCED) blood test, marking a ...
Natera's (NTRA) multi-cancer early detection assay has been granted Breakthrough Device Designation by the US Food and Drug Administration, the genetic testing company said Friday ...
Natera, Inc. Receives FDA Breakthrough Device Designation for Its Multi-Cancer Early Detection Assay
Natera, Inc. announced that its multi-cancer early detection (MCED) assay has been granted Breakthrough Device designation (BDD) by the U.S. Food and Drug Administration (FDA). The BDD is designed for ...
NORTH CHICAGO - AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration ( FDA) has granted two Breakthrough Therapy Designations (BTDs) for telisotuzumab adizutecan (Temab-A; ABBV-400 ...
Yesterday, a federal jury in the Southern District of Florida convicted a Florida man who was the Vice President of a testing laboratory and owned and operated a separate marketing company for his ...
SeaStar Medical Holding Corp. ( ICU ), a commercial-stage healthcare company, said the U.S. FDA has granted Breakthrough Device Designation to its Selective Cytopheretic Device (SCD) therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results